Indications for preoperative screening for Staphylococcus aureus (MSSA or MRSA) nasal carriage and preoperative staphylococcal load reduction (HNE LHD): Open cardiac and valve procedures Shoulder, hip or knee joint total arthroplasties: primary or revision procedures Aortic work (stent and open) and all lower limb open surgery for vascular reconstructions (bypass, endarterectomy). Iliac stents (as they […]
HNELHD_CG_23_44_Staphylococcus_aureus_bacteraemia_Mgmt Key clinical care required for all patients with SAB 1. Commence intravenous (IV) high dose flucloxacillin AND vancomycin (unless allergies) immediately, pending results of S.aureus PCR testing or susceptibilities. 2. Remove any removable foci of infection (change IV lines, drain abscesses). 3. Evaluate for complicated SAB using the criteria defined below (section 2.3). 4. […]
Guest posting: Professor Jason Trubiano Penicillin allergies are not always lifelong. Approximately 50% are lost over five years and 80% at 10 years. A reaction to penicillin, typically a benign rash during a childhood, is unlikely to be a true allergy, with more than 97% negative on allergy testing. Only 1–2% of patients with a […]
Guest posting from Dr Catherine Berry, Infectious Diseases Staff Specialist and Antimicrobial Stewardship lead for Hunter New England Health. I’m still recovering from a week of ID on call. It’s intense and we provide service for a huge area of NSW. It’s interesting and challenging trying to see the problem through the referrer’s eyes. Some […]
Here is Josh‘s regular survey – well worth a look! Top ID papers of 2023 Davis
Case load, mortality and relapse Healthcare-associated cases Community acquired cases N=83 (0.9 / 10,000 inpatient bed-days) 8% MRSA 9% Age-adjusted 30-day mortality (c.f. 9% in 2018) Relapse within 15-90 days (2019 – 2022): – 1.8% of adult events – 0% of paediatric events N=264 (2.8 / 10,000 population) 12% MRSA 7% Age-adjusted […]
Collated antibiograms compiled by Dr Rob George, Pathology NSW are now available via the HNE intranet at this location . This is the summary report : Antibiograms_2022_-_HNE_LHD
Presented between November 18-24th : Oral is the New IV presented by Professor Josh Davis and Ms Kristi Kozierowski (AMS pharmacist, John Hunter Hospital): Oral is the New IV_JHH Davis 2023 Oral is the new IV – 2023 – KK Antibiograms presented by Dr Rob George (Microbiologist, Pathology NSW) Are we looking after our antibiotics in Hunter […]
Guest posting from Professors Josh Davis (Hunter New England Health) and Patrick Harris (UQ). AMBLER CLASS Class A Class B Class D Key characteristic Serine group enzyme Metallo-betalactamase OXA-type Key example(s) KPC, GES IMP, NDM, VIM OXA-48. (OXA-181, OXA-232 emerging) Susceptiblity features R to all b-lactams R to all b-lactams except Aztreonam May harbour other […]
Here is Josh’s eclectic selection of top non-COVID papers for 2022! Top ID papers of 2022 Davis Happy New Year all from AIMED.
AIMED - Let's talk about antibiotics 